Access
To read this story in full you will need to login or make a payment (see right).
Brief Communications
Nature 405, 635 (8 June 2000) | doi:10.1038/35015164
Open Innovation Challenges
- More Challenges
- Powered by:
nature jobs
Postdoctoral Position
- Fox Chase Cancer Center
- Philadelphia, Pennsylvania, United States, 19111
Professor of Microscopy (W2)
- Friedrich-Schiller-University
- Jena Germany
Recombinant erythropoietin in urine
Françoise Lasne1 & Jacques de Ceaurriz1
Top of page
Abstract
Erythropoietin is a hormone that stimulates the production of new red blood cells (erythropoiesis). Although athletes use recombinant human erythropoietin illicitly to boost the delivery of oxygen to the tissues and enhance their performance in endurance sports, this widespread doping practice cannot be controlled in the absence of a reliable analytical procedure to monitor it. Here we describe a new technique for detecting this drug in urine following its recent administration.
To read this story in full you will need to login or make a payment (see right).
